Literature DB >> 28457739

Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact.

Byron Oppliger1, Marianne S Joerger-Messerli1, Cedric Simillion2, Martin Mueller3, Daniel V Surbek1, Andreina Schoeberlein4.   

Abstract

BACKGROUND AIMS: Wharton's jelly mesenchymal stromal cells (WJ-MSCs) might be ideal candidates to treat perinatal brain damage. Their secretome has been shown to have beneficial effects on neuroregeneration, in part through interaction with neural progenitor cells (NPCs). However, it remains unclear whether cell-to-cell contact decisively contributes to this positive effect. The objective of this study was to elucidate the mechanism through which differentiation in NPCs is triggered after exposure to WJ-MSCs. Furthermore, given that WJ-MSCs can be derived from term (tWJ-MSCs) or preterm (ptWJ-MSCs) deliveries and that WJ-MSCs might be used for transplantations independent of gestational age, the influence of tWJ-MSCs versus ptWJ-MSCs on the differentiation capacities of NPCs was studied.
METHODS: The effect of tWJ-MSCs and ptWJ-MSCs on the expression of neuroglial markers in NPCs was assessed in co-culture (CC), conditioned medium (CM) or transwell CC experiments by immunocytochemistry, real-time polymerase chain reaction and Western blot. Additionally, mass spectrometry was used to study their secretomes.
RESULTS: NPCs showed an increased expression of glial markers after CC with WJ-MSCs or exposure to WJ-MSC-CMs. CC had a more prominent effect on the expression of glial markers compared with CM or transwell CCs. tWJ-MSCs more strongly induced the expression of mature oligodendroglial markers compared with ptWJ-MSCs. A possible role in enhancing this maturation could be attributed to the laminin α2-subunit.
CONCLUSIONS: Cell-to-cell contact between WJ-MSCs and NPCs induces oligodendrogenesis on NPCs, whereas trophic factor secretion is sufficient to promote astrogenesis. Thus, transplanting WJ-MSCs may promote endogenous neuroregeneration in perinatal brain damage.
Copyright © 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Wharton's jelly; mesenchymal stromal cells; neural progenitor cells; neuroregeneration; oligodendrogenesis

Mesh:

Substances:

Year:  2017        PMID: 28457739     DOI: 10.1016/j.jcyt.2017.03.075

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  6 in total

Review 1.  Interaction of Neural Stem Cells (NSCs) and Mesenchymal Stem Cells (MSCs) as a Promising Approach in Brain Study and Nerve Regeneration.

Authors:  Agnieszka Kaminska; Klaudia Radoszkiewicz; Paulina Rybkowska; Aleksandra Wedzinska; Anna Sarnowska
Journal:  Cells       Date:  2022-04-26       Impact factor: 7.666

Review 2.  Recent Investigations on Neurotransmitters' Role in Acute White Matter Injury of Perinatal Glia and Pharmacotherapies-Glia Dynamics in Stem Cell Therapy.

Authors:  Narasimha M Beeraka; P R Hemanth Vikram; M V Greeshma; Chinnappa A Uthaiah; Tahani Huria; Junqi Liu; Pramod Kumar; Vladimir N Nikolenko; Kirill V Bulygin; Mikhail Y Sinelnikov; Olga Sukocheva; Ruitai Fan
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

3.  Human Wharton's Jelly Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Drive Oligodendroglial Maturation by Restraining MAPK/ERK and Notch Signaling Pathways.

Authors:  Marianne S Joerger-Messerli; Gierin Thomi; Valérie Haesler; Irene Keller; Patricia Renz; Daniel V Surbek; Andreina Schoeberlein
Journal:  Front Cell Dev Biol       Date:  2021-03-23

Review 4.  General consensus on multimodal functions and validation analysis of perinatal derivatives for regenerative medicine applications.

Authors:  Michela Pozzobon; Stefania D'Agostino; Maria G Roubelakis; Anna Cargnoni; Roberto Gramignoli; Susanne Wolbank; Florelle Gindraux; Sveva Bollini; Halima Kerdjoudj; Mathilde Fenelon; Roberta Di Pietro; Mariangela Basile; Veronika Borutinskaitė; Roberta Piva; Andreina Schoeberlein; Guenther Eissner; Bernd Giebel; Peter Ponsaerts
Journal:  Front Bioeng Biotechnol       Date:  2022-10-03

5.  Neuroprotective Action of Human Wharton's Jelly-Derived Mesenchymal Stromal Cell Transplants in a Rodent Model of Stroke.

Authors:  Kuo-Jen Wu; Seong-Jin Yu; Chia-Wen Chiang; Yu-Wei Lee; B Linju Yen; Pei-Chi Tseng; Chun-Sen Hsu; Li-Wei Kuo; Yun Wang
Journal:  Cell Transplant       Date:  2018-10-04       Impact factor: 4.064

Review 6.  Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury.

Authors:  Kuo-Jen Wu; Seong-Jin Yu; Chia-Wen Chiang; Yu-Wei Lee; B Linju Yen; Chun-Sen Hsu; Li-Wei Kuo; Yun Wang
Journal:  Brain Circ       Date:  2018-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.